A Tyr346→Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy

被引:41
作者
Mumford, AD
Laffan, M
O'Donnell, J
McVey, JH
Johnson, DJD
Manning, RA
Kemball-Cook, G
机构
[1] Hammersmith Hosp, Imperial Coll Med Sch, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Hammersmith Hosp, Imperial Coll, Fac Med, Dept Haematol, London W12 0NN, England
基金
英国医学研究理事会;
关键词
factor VIII; assay discrepancy; interdomain acidic region a1; factor VIII activation; FVIIIa inactivation;
D O I
10.1046/j.1365-2141.2002.03617.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interdomain acidic region a1 is a unique structural feature of coagulation factor VIII (FVIII) and may mediate the proteolytic activation of FVIII and the inactivation of FVIIIa. We report an individual with a Tyr346-->Cys substitution within region a1 , who presented with a one-stage FVIII activity (FVIII:C) of 0.34 iu/ml (normal range 0.5-2.0) but normal two-stage FVIII:C and FVIII antigen values. In a factor Xa (FXa)-generation assay for FVIII in which the activation time with thrombin was varied, the variant plasma showed normal FVIII:C at both short and long activation times. However, at intermediate activation times the FXa generation of the variant plasma was less than that of normal pooled plasma. In a modified one-stage FVIII:C assay in which partially purified FVIII was activated with thrombin at low concentrations, the variant FVIII showed less activation than wild-type FVIII, although this defect corrected with increasing concentrations of thrombin. When partially purified variant FVIII was activated with a large molar excess of thrombin, the subsequent rate of decay of FVIII:C was greater for variant FVIII. The complex defects in activation and inactivation displayed by FVIII Tyr346-->Cys support the hypothesis that the a1 sequence is a key regulator of FVIII activity.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 16 条
[1]   PROTEOLYTIC PROCESSING OF HUMAN FACTOR-VIII - CORRELATION OF SPECIFIC CLEAVAGES BY THROMBIN, FACTOR XA, AND ACTIVATED PROTEIN-C WITH ACTIVATION AND INACTIVATION OF FACTOR-VIII COAGULANT ACTIVITY [J].
EATON, D ;
RODRIGUEZ, H ;
VEHAR, GA .
BIOCHEMISTRY, 1986, 25 (02) :505-512
[2]  
FAY PJ, 1993, J BIOL CHEM, V268, P17861
[3]   Factor VIIIa cofactor activity shows enhanced ionic strength sensitivity in the absence of phospholipid [J].
Fay, PJ ;
Mastri, M ;
Koszelak, ME .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1548 (01) :159-168
[4]  
FAY PJ, 1992, J BIOL CHEM, V267, P13246
[5]  
GOODEVE AC, 2001, UNUSUAL DISCREPANT F
[6]   The Factor VIII Structure and Mutation Resource Site: HAMSTeRS Version 4 [J].
Kemball-Cook, G ;
Tuddenham, EGD ;
Wacey, AI .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :216-219
[7]  
Lapan KA, 1997, J BIOL CHEM, V272, P2082
[8]   The life cycle of coagulation factor VIII in view of its structure and function [J].
Lenting, PJ ;
van Mourik, JA ;
Mertens, K .
BLOOD, 1998, 92 (11) :3983-3996
[9]   Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction [J].
Mercuri, E ;
Cowan, F ;
Gupte, G ;
Manning, R ;
Laffan, M ;
Rutherford, M ;
Edwards, AD ;
Dubowitz, L ;
Roberts, I .
PEDIATRICS, 2001, 107 (06) :1400-1404
[10]  
MICHNICK DA, 1994, J BIOL CHEM, V269, P20095